Autolus Therapeutics (AUTL) Shares Issued (2020 - 2024)

Autolus Therapeutics (AUTL) has 5 years of Shares Issued data on file, last reported at $550.0 million in Q1 2024.

• For the quarter ending Q1 2024, Shares Issued changed N/A year-over-year to $550.0 million; the trailing twelve-month figure through Dec 2024 stood at $550.0 million (changed N/A YoY), and the FY2024 full-year result was $550.0 million, changed N/A from the prior year.
• Shares Issued for Q1 2024 stood at $550.0 million, up from -$4000.0 in the prior quarter.
• Across five years, Shares Issued topped out at $550.0 million in Q1 2024 and bottomed at -$130.9 million in Q2 2021.
• The 5-year median for Shares Issued is $121500.0 (2021), against an average of $79.4 million.
• The widest annual swing landed in 2022, when Shares Issued soared 16373800.0%; it then plunged 100.0% in 2023.
• A 5-year view of Shares Issued shows it stood at $79.7 million in 2020, then slumped by 100.0% to -$1000.0 in 2021, then jumped by 16373800.0% to $163.7 million in 2022, then slumped by 100.0% to -$4000.0 in 2023, then surged by 13749525.0% to $550.0 million in 2024.
• The last three Shares Issued figures came in at $550.0 million (Q1 2024), -$4000.0 (Q4 2023), and $4000.0 (Q3 2023), per Business Quant data.

Peer Comparison